FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4301397730> ?p ?o ?g. }

• W4301397730 abstract "Background: Immune checkpoint inhibitor therapy has changed the treatment model of metastatic bladder cancer. However, only approximately 20% of patients benefit from this therapy, and robust biomarkers to predict the effect of immunotherapy are still lacking. In this study, we aimed to investigate whether immune-related genes could be indicators for the prognosis of bladder cancer patients and the effect of immunotherapy. Methods: Based on bladder cancer dataset from the Cancer Genome Atlas (TCGA) and GSE48075, 22 immune microenvironment-related cells were identified by CIBERSORT. After performing a series of bioinformatic and machine learning approaches, we identified distinct tumor microenvironment clusters and three bladder cancer specific immune-related genes (EGFR, OAS1 and MST1R). Then, we constructed immune-related gene risk score (IRGRS) by using the Cox regression method and validated it with the IMvigor210 dataset. Results: IRGRS-high patients had a worse overall survival than IRGRS-low patients, which was consistent with the result in the IMvigor210 dataset. Comprehensive analysis shows that patients with high IRGRS scores are mainly enriched in basal/squamous type (Ba/Sq), and tumor metabolism-related pathways are more Active, with higher TP53 and RB1 gene mutation rates, lower CD4+/CD8+ T cell infiltration, higher M0 macrophage infiltration, and lower immunotherapy efficacy. In contrast, Patients with low IRGRS scores are mainly enriched in the luminal papillary type (LumP), which is associated with the activation of IL-17 and TNF signaling pathways, higher mutation rates of FGFR3 and CDKN1A genes, higher CD4+/CD8+ T cell infiltration content, and The level of M0 macrophage infiltration was relatively low, and the immunotherapy was more probably effective. Conclusion: Our study constructed an IRGRS for bladder cancer and clarified the immune and molecular characteristics of IRGRS-defined subgroups of bladder cancer to investigate the association between IRGRS and its potential implications for prognosis and immunotherapy." @default.
• W4301397730 created "2022-10-05" @default.
• W4301397730 creator A5006397303 @default.
• W4301397730 creator A5018620935 @default.
• W4301397730 creator A5028659223 @default.
• W4301397730 creator A5035464459 @default.
• W4301397730 creator A5037863447 @default.
• W4301397730 creator A5050781624 @default.
• W4301397730 creator A5075086082 @default.
• W4301397730 creator A5082225866 @default.
• W4301397730 date "2022-10-04" @default.
• W4301397730 modified "2023-09-26" @default.
• W4301397730 title "Immune-related gene risk score predicting the effect of immunotherapy and prognosis in bladder cancer patients" @default.
• W4301397730 cites W1966327575 @default.
• W4301397730 cites W1978672439 @default.
• W4301397730 cites W1985987855 @default.
• W4301397730 cites W2033775272 @default.
• W4301397730 cites W2035618305 @default.
• W4301397730 cites W2101657563 @default.
• W4301397730 cites W2115462905 @default.
• W4301397730 cites W2146512944 @default.
• W4301397730 cites W2159707944 @default.
• W4301397730 cites W2289712604 @default.
• W4301397730 cites W2559804019 @default.
• W4301397730 cites W2763129844 @default.
• W4301397730 cites W2763670669 @default.
• W4301397730 cites W2766249538 @default.
• W4301397730 cites W2785803176 @default.
• W4301397730 cites W2800568511 @default.
• W4301397730 cites W2801309958 @default.
• W4301397730 cites W2804957255 @default.
• W4301397730 cites W2887831258 @default.
• W4301397730 cites W2890512043 @default.
• W4301397730 cites W2895985564 @default.
• W4301397730 cites W2897581535 @default.
• W4301397730 cites W2920863623 @default.
• W4301397730 cites W2930852633 @default.
• W4301397730 cites W2975497362 @default.
• W4301397730 cites W2976516489 @default.
• W4301397730 cites W2987436342 @default.
• W4301397730 cites W3035420485 @default.
• W4301397730 cites W3038244404 @default.
• W4301397730 cites W3048201207 @default.
• W4301397730 cites W3080554914 @default.
• W4301397730 cites W3092222195 @default.
• W4301397730 cites W3093383535 @default.
• W4301397730 cites W3097803258 @default.
• W4301397730 cites W3102493364 @default.
• W4301397730 cites W3123927476 @default.
• W4301397730 cites W3134677330 @default.
• W4301397730 cites W3158218790 @default.
• W4301397730 cites W3177404835 @default.
• W4301397730 cites W3206224125 @default.
• W4301397730 cites W4224210658 @default.
• W4301397730 cites W4251731689 @default.
• W4301397730 doi "https://doi.org/10.3389/fgene.2022.1011390" @default.
• W4301397730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36267410" @default.
• W4301397730 hasPublicationYear "2022" @default.
• W4301397730 type Work @default.
• W4301397730 citedByCount "0" @default.
• W4301397730 crossrefType "journal-article" @default.
• W4301397730 hasAuthorship W4301397730A5006397303 @default.
• W4301397730 hasAuthorship W4301397730A5018620935 @default.
• W4301397730 hasAuthorship W4301397730A5028659223 @default.
• W4301397730 hasAuthorship W4301397730A5035464459 @default.
• W4301397730 hasAuthorship W4301397730A5037863447 @default.
• W4301397730 hasAuthorship W4301397730A5050781624 @default.
• W4301397730 hasAuthorship W4301397730A5075086082 @default.
• W4301397730 hasAuthorship W4301397730A5082225866 @default.
• W4301397730 hasBestOaLocation W43013977301 @default.
• W4301397730 hasConcept C121608353 @default.
• W4301397730 hasConcept C126322002 @default.
• W4301397730 hasConcept C143998085 @default.
• W4301397730 hasConcept C167672396 @default.
• W4301397730 hasConcept C203014093 @default.
• W4301397730 hasConcept C2776107976 @default.
• W4301397730 hasConcept C2777701055 @default.
• W4301397730 hasConcept C2780352672 @default.
• W4301397730 hasConcept C502942594 @default.
• W4301397730 hasConcept C71924100 @default.
• W4301397730 hasConcept C8891405 @default.
• W4301397730 hasConceptScore W4301397730C121608353 @default.
• W4301397730 hasConceptScore W4301397730C126322002 @default.
• W4301397730 hasConceptScore W4301397730C143998085 @default.
• W4301397730 hasConceptScore W4301397730C167672396 @default.
• W4301397730 hasConceptScore W4301397730C203014093 @default.
• W4301397730 hasConceptScore W4301397730C2776107976 @default.
• W4301397730 hasConceptScore W4301397730C2777701055 @default.
• W4301397730 hasConceptScore W4301397730C2780352672 @default.
• W4301397730 hasConceptScore W4301397730C502942594 @default.
• W4301397730 hasConceptScore W4301397730C71924100 @default.
• W4301397730 hasConceptScore W4301397730C8891405 @default.
• W4301397730 hasFunder F4320321921 @default.
• W4301397730 hasFunder F4320335787 @default.
• W4301397730 hasLocation W43013977301 @default.
• W4301397730 hasLocation W43013977302 @default.
• W4301397730 hasLocation W43013977303 @default.
• W4301397730 hasLocation W43013977304 @default.
• W4301397730 hasOpenAccess W4301397730 @default.
• W4301397730 hasPrimaryLocation W43013977301 @default.

• next